Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways

作者：Walter Gernot^*; Ruediger Ralf

来源：Cell Cycle, 2012, 11(3): 451-459.

DOI：10.4161/cc.11.3.19057

• lung cancer
• oncogenic K-ras
• p53
• A alpha mutations in endometrial cancer

Evidence that protein phosphatase 2A (PP2A) is a tumor suppressor in humans came from the discovery of mutations in the genes encoding the A alpha and A beta subunits of the PP2A trimeric holoenzymes, A alpha-B-C and A beta-B-C. One point mutation, A alpha-E64D, was found in a human lung carcinoma. It renders Aa specifically defective in binding regulatory B-1 subunits. Recently, we reported a knock-in mouse expressing A alpha-E64D and an Aa knockout mouse. The mutant mice showed a 50-60% increase in the incidence of lung cancer induced by benzopyrene. Importantly, PP2A's tumor suppressor activity depended on p53. These data provide the first direct evidence that PP2A is a tumor suppressor in mice. In addition, they suggest that PP2A is a tumor suppressor in humans. Here, we report that PP2A functions as a tumor suppressor in mice that develop lung cancer triggered by oncogenic K-ras. We discuss whether PP2A may function as a tumor suppressor in diverse tissues, with emphasis on endometrial and ovarian carcinomas, in which A alpha mutations were detected at a high frequency. We propose suitable mouse models for examining whether PP2A functions as tumor suppressor in major growth-stimulatory signaling pathways, and we discuss the prospect of using the PP2A activator FTY720 as a drug against malignancies that are driven by these pathways.

• 出版日期2012-2-1